Pacira BioSciences
PCRX
PCRX
168 hedge funds and large institutions have $1.36B invested in Pacira BioSciences in 2018 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 58 increasing their positions, 60 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
36% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 42
57% less call options, than puts
Call options by funds: $12M | Put options by funds: $27.9M
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
168
Holding in Top 10
2
Calls
$12M
Puts
$27.9M
Top Buyers
| 1 | +$53.1M | |
| 2 | +$32.2M | |
| 3 | +$27M | |
| 4 |
PC
PointState Capital
New York
|
+$26.4M |
| 5 |
Jennison Associates
New York
|
+$16M |
Top Sellers
| 1 | -$23.3M | |
| 2 | -$17.8M | |
| 3 | -$16.2M | |
| 4 |
HM
HealthCor Management
New York
|
-$15.6M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$15.3M |